The predicted stiffness of myeloma BMSC via this ODE system was changed from 400 to 526pa following treatment with 5nM SDF-1, which was very close to the experimental results (400–530 pa) shown in the Choi's work [10]. The gene discussed is CXCL12; the disease is plasma cell myeloma.